Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. - Wikidata - awgldk - TriplyDB

Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.

Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.

http://www.wikidata.org/entity/Q34762475

about

Diabetic retinopathy and systemic factors Advanced Glycation End Products Impair Voltage-Gated K+ Channels-Mediated Coronary Vasodilation in Diabetic Rats Biomarkers in Diabetic Retinopathy Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments.New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.Oxidation as an important factor of protein damage: Implications for Maillard reaction.The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Diabetic retinopathy: current understanding, mechanisms, and treatment strategies High serum level of methylglyoxal-derived AGE, Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction.Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.Involvement of advanced glycation end-products in 'hyperglycemic memory'.Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study - protocol for a multicentre cross-sectional study.Alendronate Can Improve Bone Alterations in Experimental Diabetes by Preventing Antiosteogenic, Antichondrogenic, and Proadipocytic Effects of AGEs on Bone Marrow Progenitor Cells.Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration.DAF in diabetic patients is subject to glycation/inactivation at its active site residues.Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.Glycated Collagen Stimulates Differentiation of Gingival Myofibroblasts.

P2860

Q28082046-1165E7BB-AB1B-4787-B6CC-C718C0B0DECA Q28550923-DF37E238-6C9F-458D-811C-7983E8C7B611 Q33583030-A0622C09-83EC-4445-AA48-4BAB149053CC Q36030387-ED214182-2C78-4EC7-A0CD-7D3FAD984508 Q36530332-A3B7E73C-8C33-4F4E-8B7D-D08C9FB1A2D8 Q37025662-E3C4CA89-8524-475D-94D4-3290801398C1 Q37156152-3699A23B-26F9-44F3-BDDB-F9AF8C6640EE Q38365343-526C12E8-D712-4546-82A0-85667F8790A8 Q38394355-0D78CFA8-660B-43FE-AD35-A887FF7974C6 Q38473579-8E3BC42E-FE08-4642-82DF-C52CB80366EF Q38848764-5ECECD2D-A606-4D35-B769-3147008A5EA1 Q38956425-A7A9A3C9-AA82-4FCA-A065-F27E8693345A Q39285661-F33914D4-3D3F-4F4C-A2A0-1AB5CCDB032D Q39445950-242E0407-191F-41E9-A991-AC5B7A3E0461 Q39655031-17C2F47D-25C1-4403-9895-A043F1D971EF Q40298930-DA3C84F5-FC2D-4526-9BCC-E92F9E6F109B Q40716419-1BF5D56A-79B2-4C86-9B5D-8A46EC6BE929 Q41226294-ED51B9E5-E237-4F7F-B4B1-7358BA39584C Q42374979-EAC12BBF-9529-4EEB-971D-B8FC1D3F0820 Q44870873-41261C16-2997-455E-B440-4896F0EA2E78 Q47832785-B8BB976B-5879-493A-93E8-565806A840C4 Q50598315-D7CF8F07-E09C-464B-A6B4-20F00BBF9F6E Q50995216-07400442-4631-418A-A136-096F2053B55E

P2860

Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.

http://www.wikidata.org/entity/Q34762475

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@ast

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@en

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@nl

type

label

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@ast

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@en

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@nl

prefLabel

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@ast

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@en

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@nl

P1433

Q34762475-09AC0D2F-8E6C-4A9D-B837-29ECA9466B73

P1476

Q34762475-0EDD6B7C-7C54-4B66-B1BC-CC19A889875B

P2093

Q34762475-3C2B3B0B-9832-4D28-BFCE-D986D526D043

Q34762475-495572EE-C8BD-41E0-903C-E84ADAD07F65

Q34762475-651982EB-DE9F-4E02-B13D-479F91187E98

Q34762475-A24A48ED-EFDA-4A69-8C9F-465F011D7C5F

Q34762475-C239E814-EEBD-4697-8724-4DC2DB874262

Q34762475-F348DFE8-0614-46C1-BF13-9C4A2771953E

Q34762475-F364D6FB-4A21-426E-8473-EBE7E64CD1CA

P2860

Q34762475-0854F357-CAA9-4EF9-9DE0-4443779BA522

Q34762475-11F69A3C-DE29-4341-AE9D-4BAC39DE892C

Q34762475-142A053A-9BD7-49F2-ACB2-1F33AF55C168

Q34762475-1B16CCA4-4290-4921-AB0E-4F6616B8A81D

Q34762475-1E1D3191-9EC0-415B-A965-F39DE81DCD07

Q34762475-2AEC61D3-CA99-46FB-ABA9-5F0FDFC38ADF

Q34762475-2C6138F9-540E-4F6A-A366-E98E276568FC

Q34762475-465A4182-F741-41A5-BAF8-5028920B43E1

Q34762475-46F5966D-D738-424B-BF1E-BCF14C5A60C3

Q34762475-474112B1-5439-46CB-996D-1B7EDAC61C34

P304

Q34762475-9BABD43A-62C0-49CF-B366-F25B820E2204

P31

Q34762475-1E6B2B28-D7CE-4D6D-87BE-8A09626DCE1E

P356

Q34762475-9DD4C25C-B198-4CD0-97B4-C30FE9369717

P407

Q34762475-3CAD3144-0C07-4AFE-806E-66C58A8000D0

P433

Q34762475-A661C3F5-43F7-40F0-B33F-CC10492D1285

P478

Q34762475-CAFDE83A-ECF8-4CFC-A27E-DA36890F56F8

P50

Q34762475-6621BCE0-DF17-4ED4-8416-AD1CEA3001B0

P577

Q34762475-0A2C5FFA-404F-443D-A3C9-874F747BC36F

P698

Q34762475-65853D0C-5A42-41B3-A3A3-43923EFCA319

P921

Q34762475-358D64FC-4899-4C0E-A32C-94173832EE29

P932

Q34762475-2BDEA30E-6ACC-47E5-8AAF-2DFC1E3113BD

P356

P1433

P1476

Skin advanced glycation end pr ...... rogression of type 1 diabetes.

@en

P2093

DCCT/EDIC Research Group

http://www.w3.org/2001/XMLSchema#string

David R Sell

http://www.w3.org/2001/XMLSchema#string

Patricia Cleary

http://www.w3.org/2001/XMLSchema#string

Saul Genuth

http://www.w3.org/2001/XMLSchema#string

Vincent M Monnier

http://www.w3.org/2001/XMLSchema#string

Wanjie Sun

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Gao

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus

Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal.

Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring.

Glycation products as markers and predictors of the progression of diabetic complications.

The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.

P304

266-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB14-0215

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25187362

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4274803

http://www.w3.org/2001/XMLSchema#string